September 14, 2026 09:06 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Gurugram horror caught on camera: ‘I felt unsafe’—car chases, rams woman biker and flees | BRICS veg menu row: ‘Why shouldn’t we showcase it?’—Harsh Goenka hits back after Rahul Gandhi’s ‘80%’ remark | India-UAE Comprehensive Strategic Partnership in focus: Modi meets Abu Dhabi Crown Prince on BRICS sidelines | Xi Jinping lands in India for BRICS; big Modi meeting set for New Delhi | ‘Hospitality on another level’: South African official stunned by India’s BRICS hosting | Suvendu Adhikari eats fish bhog at Kalighat Temple amid Bageshwar Baba row | Bangladeshi Hindu monk Chinmoy Krishna Das breaks down emotionally as he gets 5-hour parole to attend mother’s funeral | Sheikh Hasina’s daughter Saima Wazed quits WHO post amid fraud allegations | After days of silence, China confirms Xi Jinping’s India visit for BRICS Summit | Big setback for Abhishek Banerjee as CID arrests aide Sumit Roy

Genpact appoints Hanspeter Spek as Director

| | Apr 04, 2014, at 12:08 am
New York, Apr 3 (IBNS): Business process management company Genpact Limited on Thursday announced Hanspeter Spek as a member of its Board of Directors.
“We are honored to have Hanspeter join the Genpact Board. With his extensive global experience, he will bring significant value to Genpact and its Board,” said Robert Scott, Chairman of the Board, Genpact. 
 
Spek, who also currently serves as Chairman of the Board of Sanofi Germany, spent his career in the pharmaceutical industry where he most recently served as president of Global Operations at Sanofi S.A. before retiring in June 2013. 
 
Beginning his career at Pfizer, where he spent more than 10 years in increasingly responsible product and marketing management roles,Spek then joined Sanofi in 1985. 
 
His tenure there spanned a number of senior management roles including senior vice president of Europe following the merger with Synthélabo in 1999, director of Worldwide Operations of Sanofi-Synthélabo, and executive vice president of Global Pharmaceutical Operations for Sanofi-Aventis before he was promoted to president of Global Operations in 2009. 
 
A native of Germany, he currently resides in Paris.
 
“Genpact is thrilled to add another outstanding business leader to our Board. Hanspeter, who has had such a long and distinguished career in the pharmaceutical and life sciences industry, will bring great insights in one of our core focus industries,” said NV ‘Tiger’ Tyagarajan, president and CEO, Genpact. 
 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.